ALZIC
Therapeutic class: Bisphosphonates
Indication: Hypercalcemia of malignancy, Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy
A vial of 4 mg 4 mg in a 100 mL single-use bag
Store in a cool and dry place 20°C to 25°C (68°F to 77°F) Shelf Life: 2 Years
